Newcastle University
Toggle Main Menu
Toggle Search
Home
Browse
Latest
Stats
Policies
About
Home
Browse
Latest
Policies
About
ePrints
Browse by author
Browsing publications by
Dr Olivier Govaere
Newcastle Authors
Title
Year
Full text
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Zaki
et al.
Caucasian Lean Subjects with Non-Alcoholic Fatty Liver Disease Share Long-Term Prognosis of Non-Lean: Time for Reappraisal of BMI-Driven Approach?
2021
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Pierre Bedossa
Dr Massimo Younes
Professor Ann Daly
et al.
NASH limits anti-tumor surveillance in immunotherapy-treated HCC
2021
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Quentin Anstee
Professor Fiona Oakley
Bone Morphogenic Protein 8B Promotes the Progression of Non-Alcoholic Steatohepatitis
2020
Dr Olivier Govaere
Professor Quentin Anstee
Erratum: Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC
2020
Professor Quentin Anstee
Dr Rebecca Darlay
Dr Simon Cockell
Dr Olivier Govaere
Dr Dina Tiniakos
et al.
Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort
2020
Dr Olivier Govaere
Professor Quentin Anstee
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of
AAT
(Pi∗MZ vs Pi∗ZZ genotype) and Noncarriers
2020
Dr Olivier Govaere
Macrophages and scavenger receptors in obesity-associated non-alcoholic liver fatty disease (NAFLD)
2020
Dr Massimo Younes
Dr Olivier Govaere
Dr Dina Tiniakos
Professor Alastair Burt
Marco Zaki
et al.
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease
2020
Dr Massimo Younes
Dr Olivier Govaere
Dr Luca Miele
Dr Dina Tiniakos
Professor Alastair Burt
et al.
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver Disease
2020
Dr Olivier Govaere
Dr Simon Cockell
Dr Dina Tiniakos
Dr Rachel Queen
Dr Massimo Younes
et al.
Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis
2020
1
2
3
4
5